Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid

Halozyme Therapeutics plans to acquire Evotec for €2 billion, enhancing drug discovery capabilities. Evotec's shares surge, reflecting its potential value amid competitive differentiation and market presence.

European stocks head marginally lower; UK economy contracted in September

European stocks struggle as UK growth contracts, inflation rises in France, and crude prices drop amid China's economic concerns and increased U.S. oil inventories.

Europe's STOXX 600 falls as tech, healthcare shares drag

The STOXX 600 index fell 0.5% due to declines in technology and healthcare stocks, marking its fourth consecutive weekly drop amid concerns over U.S.-China relations and economic conditions.

After-hours movers: Applied Materials, Domino's Pizza, Evotec

After-hours stock movements include declines in Applied Materials and gains in Domino's Pizza, Evotec, and Palantir, with significant developments driving these changes.

Earnings call: Halozyme raises full-year guidance on strong Q3 performance